Area(s) of Specialization: Medical mycology, fungi-bacteria interactions, bacterial multidrug resistance (MDR) efflux pumps, and antimicrobial development.
We are interested in understanding the pathogenic mechanisms of Candida albicans, the major fungal pathogen of humans, and in developing novel antifungal agents for therapeutic use. C. albicans and other Candida species cause mucosal, disseminated and invasive infections, especially among patients who are immune suppressed or hospitalized with diseases such as cancer or HIV.
We are also interested in deciphering the molecular mechanisms of antimicrobial resistance in bacterial pathogens, particularly contribution of multiple drug resistance (MDR) by efflux pumps which eliminate drugs from the bacteria.
Research Focus:
- Candida albicans is commensal and an opportunistic human fungal pathogen
Research: Biology – Studies pathogenesis of Candida albicans and multidrug resistance (MDR) efflux pumps in bacteria
Subject areas:
- Microbiology and Immunology
- Genetics, Developmental and Cell Biology
